Episode Details
Back to Episodes
Simon Malpas: Kitea Health co-founder on the company winning spots on two FDA fast-track programmes
Published 1 year, 2 months ago
Description
Kiwi start-up Kitea Health has experienced a successful start to 2025.
In the last three months, Kitea has secured a place in the FDA fast track programme and they’ve completed a world first - implanting one of their sensors into the brain of a child.
The company has also revealed it's $7 million and counting into a $10 million funding round.
Kitea Health co-founder Simon Malpas says their product went through 10 years of research before getting started.
"We're so pleased for Kitea to be in our clinical trials - and in Auckland City Hospital, treating Kiwis. It's just a fantastic position to be in."
LISTEN ABOVE
See omnystudio.com/listener for privacy information.